Menarini Group and Insilico Medicine enter into a second exclusive global licensing agreement for an AI-developed preclinical
Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly owned subsidiary of Menarini Group focused on providing transformative oncology treatments to cancer…